A STUDY has suggested that the
pesticide DDT could increase the
chances of developing Alzheimer’s
disease.
Published in JAMA Neurology,
‘Elevated Serum Pesticide Levels
and Risk for Alzheimer Disease’
found that people with Alzheimer’s
had 3.8 times higher levels of DDE
(the metabolite of DDT) vs controls.
“Elevated serum DDE levels are
associated with an increased risk
for AD.”
However the BBC reported that
the picture was not clear cut
with some healthy people having
high levels of DDE and some with
Alzheimer’s having low levels.
To read the JAMA Neurology
abstract CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 29 Jan 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Jan 14
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.